Oncology Impact Fund (Cayman) Management L.P., 10% Owner at Cullinan Oncology, Inc. (CGEM), sold 210,075 shares at $29.48 ($6.2M) on 2021-08-24, disclosed to the SEC on 2021-08-25.
Open-market sale of $6.2M CGEM by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.11 | 53,359 | $1.6M | 25.2% |
| 2 | $29.11 | 53,359 | $1.6M | 25.2% |
| 3 | $29.48 | 50,822 | $1.5M | 24.4% |
| 4 | $29.48 | 50,822 | $1.5M | 24.4% |
| 5 | $29.09 | 1,713 | $50K | 0.8% |
| Total | $29.29 avg | 210,075 |
| $6.2M |
| 100% |
| Filing → |
| ITOS | SELL | 2021-11-24 | $8.9M | — | Filing → |
| ITOS | SELL | 2021-10-18 | $1.6M | — | Filing → |
| ITOS | SELL | 2021-10-12 | $4.6M | — | Filing → |